Whitehawk Therapeutics WHWK
NASDAQ WHWK
$3.70 -0.06 (-1.60%)
At close: Oct 2, 2026 · 4:00 PM EDT

Whitehawk Therapeutics (WHWK) Asset Writedowns and Impairment (2021)

Updated

Whitehawk Therapeutics (WHWK) posted Asset Writedowns and Impairment of $3.72 million for FY2022, down 95.0% from $74.16 million in FY2021.

Analysis

Whitehawk Therapeutics (WHWK) Asset Writedowns and Impairment (2021) Analysis & Trends

  • Business Quant data shows WHWK's Asset Writedowns and Impairment at $74.16 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Whitehawk Therapeutics 306.68 Mn 306.68 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 74.16 Mn
API Access

Whitehawk Therapeutics Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=WHWK&period=max&api_key=YOUR_API_KEY